ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
HanAll Biopharma Reports Full-Year 2021 Results and Provides Business Update
January 21, 2022HanAll Biopharma (KRX: 009420.KS) announced today that it achieved 101.6 billion won in sales in 2021, a 15% increase from the previous year. It had 10.1 billion won in operating profit, a 70% increase year-on-year... -
HanAll Biopharma Reports Second Quarter 2021 Results
July 29, 2021HanAll Biopharma announced today that the company had achieved sales of 23.4 billion won, operating profit of 1.6 billion won, and net profit of 3.3 billion won in the second quarter of 2021.
Pharma Sources Insight January 2025
